Repeat Single-Session Stereotactic Radiosurgery for Cerebral Arteriovenous Malformations: A Systematic Review, Meta-Analysis, and International Stereotactic Radiosurgery Society Practice Guidelines
- 24 June 2024
- journal article
- review article
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 96 (1) , 29-40
Abstract
BACKGROUND AND OBJECTIVES: Repeat stereotactic radiosurgery (SRS) for residual arteriovenous malformations (AVMs) can be considered as a salvage approach after failure of initial SRS. There are no published guidelines regarding patient selection, timing, or SRS parameters to guide clinical practice. This systematic review aimed to review outcomes and complications from the published literature to inform practice recommendations provided on behalf of the International Stereotactic Radiosurgery Society. METHODS: We performed a systematic review and meta-analysis following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. A comprehensive search of MEDLINE, Scopus, Web of Science, and Embase was conducted. Fourteen studies with 925 patients met the inclusion criteria. Patients were treated between 1985 and 2022. All studies were retrospective, except for one prospective cohort. RESULTS: The median patient age at repeat SRS ranged from 32 to 60 years. Four studies (630 patients) reported detailed information on Spetzler–Martin grade at the time of repeat SRS; 12.54% of patients had Spetzler–Martin grade I AVMs (79/630 patients), 46.51% had grade II (293/630), 34.92% had grade III (220/630), 5.08% had grade IV (32/630), and 0.95% had grade V (6/630). The median prescription doses varied between 15 and 25 Gy (mean, 13.06-22.8 Gy). The pooled overall obliteration rate at the last follow-up after repeat SRS was 59% (95% CI 51%-67%) with a median follow-up between 21 and 50 months. The pooled hemorrhage incidence at the last follow-up was 5% (95% CI 4%-7%), and the pooled overall radiation-induced change incidence was 12% (95% CI 7%-20%). CONCLUSION: For an incompletely obliterated AVM, repeat radiosurgery after 3 to 5 years of follow-up from the first SRS provides a reasonable benefit to the risk profile. After repeat SRS, obliteration is achieved in the majority of patients. The risk of hemorrhage or radiation-induced change appears low, and International Stereotactic Radiosurgery Society recommendations are presented.Keywords
This publication has 43 references indexed in Scilit:
- Gamma Knife radiosurgery for cerebral arteriovenous malformations: a systematic review and meta-analysisNeurosurgical Review, 2022
- Upfront and Repeated Gamma-Knife Radiosurgery for Small (≤5 mL) Unruptured Brain Arteriovenous Malformation: A Cohort of 249 Consecutive PatientsWorld Neurosurgery, 2022
- Management of Residual Brain Arteriovenous Malformations After Stereotactic RadiosurgeryWorld Neurosurgery, 2018
- Long-Term Outcomes of Single-Session Stereotactic Radiosurgery for Cerebellar Arteriovenous Malformation, with a Median Follow-Up of 10 YearsWorld Neurosurgery, 2017
- Repeat radiosurgery for cerebral arteriovenous malformationsJournal of Clinical Neuroscience, 2015
- LINAC radiosurgery for cerebral arteriovenous malformations: A single centre prospective analysis and review of the literatureJournal of Clinical Neuroscience, 2014
- Bevacizumab for refractory adverse radiation effects after stereotactic radiosurgeryJournal of Neuro-Oncology, 2013
- Stereotactic radiosurgery of cerebral arteriovenous malformations: long-term follow-up in 164 patients of a single institutionJournal of Neurology, 2013
- Clinical outcome after repeated radiosurgery for brain arteriovenous malformationsRadiotherapy and Oncology, 2010
- Meta-analysis of Observational Studies in EpidemiologyA Proposal for ReportingJAMA, 2000